Home /Research /ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival.
SURGICAL

ASO Visual Abstract: Re-evaluating the Role of Neoadjuvant Chemotherapy in Early-Stage Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival.

Ashraf A, Wang J, Hernandez S, Foroutani L, Hernandez FR, Hirose K, Nakakura E, Corvera C, Alseidi A, Adam MA

Year
2026
Journal
Annals of surgical oncology

Keywords

pancreatic cancerneoadjuvant chemotherapyimmortal time biassurvival analysisearly-stage

Related papers

Browse all SURGICAL papers